High-dose adrenomedullin effective against steroid-resistant ulcerative colitis
Adults with steroid-resistant ulcerative colitis may fare well with the vasodilatory peptide adrenomedullin at a high dose, which has been shown to induce complete remission within 8 weeks in a phase IIa trial.
High-dose adrenomedullin effective against steroid-resistant ulcerative colitis
11 Feb 2021
